Cargando…

Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract

BACKGROUND: To assess inter-observer variability in delineating target volume and organs at risk in benign tumor adjacent to optic tract as a quality assurance exercise. METHODS: We quantitatively analyzed 21 plans made by 11 clinicians in seven CyberKnife centers. The clinicians were provided with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Hideya, Shiomi, Hiroya, Tsubokura, Takuji, Kodani, Naohiro, Nishimura, Takuya, Aibe, Norihiro, Udono, Hiroki, Nishikata, Manabu, Baba, Yoshimi, Ogita, Mikio, Yamashita, Koichi, Kotsuma, Tadayuki
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040152/
https://www.ncbi.nlm.nih.gov/pubmed/21272369
http://dx.doi.org/10.1186/1748-717X-6-10
_version_ 1782198278686769152
author Yamazaki, Hideya
Shiomi, Hiroya
Tsubokura, Takuji
Kodani, Naohiro
Nishimura, Takuya
Aibe, Norihiro
Udono, Hiroki
Nishikata, Manabu
Baba, Yoshimi
Ogita, Mikio
Yamashita, Koichi
Kotsuma, Tadayuki
author_facet Yamazaki, Hideya
Shiomi, Hiroya
Tsubokura, Takuji
Kodani, Naohiro
Nishimura, Takuya
Aibe, Norihiro
Udono, Hiroki
Nishikata, Manabu
Baba, Yoshimi
Ogita, Mikio
Yamashita, Koichi
Kotsuma, Tadayuki
author_sort Yamazaki, Hideya
collection PubMed
description BACKGROUND: To assess inter-observer variability in delineating target volume and organs at risk in benign tumor adjacent to optic tract as a quality assurance exercise. METHODS: We quantitatively analyzed 21 plans made by 11 clinicians in seven CyberKnife centers. The clinicians were provided with a raw data set (pituitary adenoma and meningioma) including clinical information, and were asked to delineate the lesions and create a treatment plan. Their contouring and plans (10 adenoma and 11 meningioma plans), were then compared. In addition, we estimated the influence of differences in contouring by superimposing the respective contours onto a default plan. RESULTS: The median planning target volume (PTV) and the ratio of the largest to the smallest contoured volume were 9.22 cm(3 )(range, 7.17 - 14.3 cm(3)) and 1.99 for pituitary adenoma, and 6.86 cm(3 )(range 6.05 - 14.6 cm(3)) and 2.41 for meningioma. PTV volume was 10.1 ± 1.74 cm(3 )for group 1 with a margin of 1 -2 mm around the CTV (n = 3) and 9.28 ± 1.8 cm(3)(p = 0.51) for group 2 with no margin (n = 7) in pituitary adenoma. In meningioma, group 1 showed larger PTV volume (10.1 ± 3.26 cm(3)) than group 2 (6.91 ± 0.7 cm(3), p = 0.03). All submitted plan keep the irradiated dose to optic tract within the range of 50 Gy (equivalent total doses in 2 Gy fractionation). However, contours superimposed onto the dose distribution of the default plan indicated that an excessive dose 23.64 Gy (up to 268% of the default plan) in pituitary adenoma and 24.84 Gy (131% of the default plan) in meningioma to the optic nerve in the contours from different contouring. CONCLUSION: Quality assurance revealed inter-observer variability in contour delineation and their influences on planning for pituitary adenoma and meningioma near optic tract.
format Text
id pubmed-3040152
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30401522011-02-17 Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract Yamazaki, Hideya Shiomi, Hiroya Tsubokura, Takuji Kodani, Naohiro Nishimura, Takuya Aibe, Norihiro Udono, Hiroki Nishikata, Manabu Baba, Yoshimi Ogita, Mikio Yamashita, Koichi Kotsuma, Tadayuki Radiat Oncol Research BACKGROUND: To assess inter-observer variability in delineating target volume and organs at risk in benign tumor adjacent to optic tract as a quality assurance exercise. METHODS: We quantitatively analyzed 21 plans made by 11 clinicians in seven CyberKnife centers. The clinicians were provided with a raw data set (pituitary adenoma and meningioma) including clinical information, and were asked to delineate the lesions and create a treatment plan. Their contouring and plans (10 adenoma and 11 meningioma plans), were then compared. In addition, we estimated the influence of differences in contouring by superimposing the respective contours onto a default plan. RESULTS: The median planning target volume (PTV) and the ratio of the largest to the smallest contoured volume were 9.22 cm(3 )(range, 7.17 - 14.3 cm(3)) and 1.99 for pituitary adenoma, and 6.86 cm(3 )(range 6.05 - 14.6 cm(3)) and 2.41 for meningioma. PTV volume was 10.1 ± 1.74 cm(3 )for group 1 with a margin of 1 -2 mm around the CTV (n = 3) and 9.28 ± 1.8 cm(3)(p = 0.51) for group 2 with no margin (n = 7) in pituitary adenoma. In meningioma, group 1 showed larger PTV volume (10.1 ± 3.26 cm(3)) than group 2 (6.91 ± 0.7 cm(3), p = 0.03). All submitted plan keep the irradiated dose to optic tract within the range of 50 Gy (equivalent total doses in 2 Gy fractionation). However, contours superimposed onto the dose distribution of the default plan indicated that an excessive dose 23.64 Gy (up to 268% of the default plan) in pituitary adenoma and 24.84 Gy (131% of the default plan) in meningioma to the optic nerve in the contours from different contouring. CONCLUSION: Quality assurance revealed inter-observer variability in contour delineation and their influences on planning for pituitary adenoma and meningioma near optic tract. BioMed Central 2011-01-27 /pmc/articles/PMC3040152/ /pubmed/21272369 http://dx.doi.org/10.1186/1748-717X-6-10 Text en Copyright ©2011 Yamazaki et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Yamazaki, Hideya
Shiomi, Hiroya
Tsubokura, Takuji
Kodani, Naohiro
Nishimura, Takuya
Aibe, Norihiro
Udono, Hiroki
Nishikata, Manabu
Baba, Yoshimi
Ogita, Mikio
Yamashita, Koichi
Kotsuma, Tadayuki
Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract
title Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract
title_full Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract
title_fullStr Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract
title_full_unstemmed Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract
title_short Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract
title_sort quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040152/
https://www.ncbi.nlm.nih.gov/pubmed/21272369
http://dx.doi.org/10.1186/1748-717X-6-10
work_keys_str_mv AT yamazakihideya quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT shiomihiroya quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT tsubokuratakuji quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT kodaninaohiro quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT nishimuratakuya quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT aibenorihiro quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT udonohiroki quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT nishikatamanabu quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT babayoshimi quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT ogitamikio quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT yamashitakoichi quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract
AT kotsumatadayuki quantitativeassessmentofinterobservervariabilityintargetvolumedelineationonstereotacticradiotherapytreatmentforpituitaryadenomaandmeningiomanearoptictract